BPC
Banque Pictet & Cie Portfolio holdings
AUM
$9.6B
1-Year Return
7.6%
This Quarter Return
+13.05%
1 Year Return
+7.6%
3 Year Return
+57.9%
5 Year Return
+121.14%
10 Year Return
+318.59%
AUM
$10.3B
AUM Growth
+$723M
(+7.5%)
Cap. Flow
-$125M
Cap. Flow
% of AUM
-1.21%
Top 10 Holdings %
Top 10 Hldgs %
46.69%
Holding
642
New
37
Increased
178
Reduced
295
Closed
77
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$557M |
| 2 |
Estee Lauder
EL
|
+$178M |
| 3 |
Eli Lilly
LLY
|
+$16.2M |
| 4 |
TSMC
TSM
|
+$15.8M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$11.4M |
Top Sells
| 1 |
3M
MMM
|
+$160M |
| 2 |
Visa
V
|
+$58.2M |
| 3 |
UnitedHealth
UNH
|
+$41.4M |
| 4 |
Walt Disney
DIS
|
+$22.8M |
| 5 |
Procter & Gamble
PG
|
+$15.2M |
Sector Composition
| 1 | Consumer Discretionary | 24% |
| 2 | Healthcare | 19.22% |
| 3 | Consumer Staples | 11.45% |
| 4 | Technology | 11.43% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Gilead Sciences
GILD
$144B
| $1.04M | 0.01% |
12,531
-2,854
| -19% | -$237K |
|
377
Algonquin Power & Utilities
AQN
$4.31B
| $1.04M | 0.01% |
124,042
+83,097
| +203% | +$696K |
|
378
Liberty Global Class A
LBTYA
$3.94B
| $1.04M | 0.01% |
53,158
+9,223
| +21% | +$180K |
|
379
Technology Select Sector SPDR Fund
XLK
$84.7B
| $1.02M | 0.01% |
6,776
+594
| +10% | +$89.7K |
|
380
Alnylam Pharmaceuticals
ALNY
$63.2B
| $1.02M | 0.01% |
5,107
-2,316
| -31% | -$464K |
|
381
Aptiv
APTV
$17.9B
| $1.01M | 0.01% |
+9,020
| New | +$1.01M |
|
382
PPG Industries
PPG
$24.7B
| $1.01M | 0.01% |
7,571
-7,342
| -49% | -$981K |
|
383
iShares MSCI United Kingdom ETF
EWU
$2.92B
| $993K | 0.01% |
30,782
+6,595
| +27% | +$213K |
|
384
Jack Henry & Associates
JKHY
$11.9B
| $983K | 0.01% |
6,522
+1,832
| +39% | +$276K |
|
385
Seagate
STX
$40.7B
| $982K | 0.01% |
14,859
-21,368
| -59% | -$1.41M |
|
386
McKesson
MCK
$87.8B
| $981K | 0.01% |
2,756
-617
| -18% | -$220K |
|
387
Wabtec
WAB
$32.5B
| $976K | 0.01% |
9,657
-6,605
| -41% | -$668K |
|
388
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.94B
| $972K | 0.01% |
14,320
| – | – |
|
389
SPDR Euro Stoxx 50 ETF
FEZ
$4.56B
| $959K | 0.01% |
21,349
+11,499
| +117% | +$516K |
|
390
Clorox
CLX
$15.4B
| $954K | 0.01% |
6,028
-11,217
| -65% | -$1.77M |
|
391
Emcor
EME
$27.9B
| $930K | 0.01% |
5,719
-6,497
| -53% | -$1.06M |
|
392
Verizon
VZ
$184B
| $909K | 0.01% |
23,366
-9,517
| -29% | -$370K |
|
393
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.83B
| $906K | 0.01% |
+8,293
| New | +$906K |
|
394
iShares Core S&P Small-Cap ETF
IJR
$85.3B
| $900K | 0.01% |
9,305
+300
| +3% | +$29K |
|
395
Carlyle Group
CG
$23B
| $870K | 0.01% |
28,000
| – | – |
|
396
Neurocrine Biosciences
NBIX
$14.3B
| $867K | 0.01% |
8,564
-3,883
| -31% | -$393K |
|
397
Dimensional US Marketwide Value ETF
DFUV
$12.1B
| $865K | 0.01% |
25,825
| – | – |
|
398
Ascendis Pharma
ASND
$12.3B
| $857K | 0.01% |
7,997
-3,626
| -31% | -$389K |
|
399
Sempra
SRE
$52.4B
| $853K | 0.01% |
11,284
-12,890
| -53% | -$974K |
|
|
SAGE
400
DELISTED
Sage Therapeutics
SAGE
| $849K | 0.01% |
20,223
+207
| +1% | +$8.69K |
|